CC
Caxton Corp
13F filer · CIK 0001388551Reported Aug 14, 2026
13F portfolio value$1.85MU.S. long equity reported on 13F
Positions9Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight87.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20269 positions | |||||
| $445K | 24.03% | Not reported | New | Q2 2026 | |
| $377K | 20.35% | Not reported | +3.7% | Q2 2015 | |
| $247K | 13.32% | 0.00% | Not reported | Q3 2019 | |
| $188K | 10.16% | 0.00% | New | Q2 2026 | |
| $110K | 5.94% | 0.02% | -34.2% | Q1 2024 | |
| $79K | 4.26% | 0.02% | +21.7% | Q4 2023 | |
| $72.7K | 3.92% | 0.02% | Not reported | Q4 2025 | |
| $57.8K | 3.12% | 0.02% | Not reported | Q4 2024 | |
| $43.4K | 2.34% | 0.02% | Not reported | Q1 2026 | |
| Q1 2026Reported May 14, 20267 positions | |||||
| $3.28M | 81.50% | 0.00% | +9.5% | Q2 2020 | |
| $348K | 8.66% | Not reported | +2.4% | Q2 2015 | |
| $162K | 4.03% | 0.03% | Not reported | Q1 2024 | |
| $80K | 1.99% | 0.02% | Not reported | Q4 2023 | |
| $64.2K | 1.60% | 0.02% | Not reported | Q4 2025 | |
| $47.8K | 1.19% | 0.02% | Not reported | Q4 2024 | |
| $42K | 1.04% | 0.02% | New | Q1 2026 | |
| Q4 2025Reported Feb 13, 202611 positions | |||||
| $2.76M | 64.50% | 0.00% | -4.4% | Q2 2020 | |
| $357K | 8.34% | Not reported | +9.1% | Q2 2015 | |
| $292K | 6.83% | 0.01% | New | Q4 2025 | |
| $210K | 4.91% | Not reported | -41.9% | Q1 2024 | |
| $176K | 4.12% | 0.03% | -18.3% | Q1 2024 | |
| $158K | 3.70% | 0.02% | -44.9% | Q4 2022 | |
| $138K | 3.24% | 0.02% | -19.6% | Q4 2023 | |
| $62.2K | 1.45% | 0.02% | New | Q4 2025 | |
| $58.3K | 1.36% | 0.02% | +73.6% | Q4 2024 | |
| $39.4K | 0.92% | 0.02% | -3.7% | Q3 2025 | |
| $27.1K | 0.63% | 0.02% | Not reported | Q2 2024 | |
| Q3 2025Reported Nov 14, 202512 positions | |||||
| $18.7M | 81.70% | 2.18% | +23.9% | Q4 2020 | |
| $2.59M | 11.33% | 0.00% | +47.1% | Q2 2020 | |
| $327K | 1.43% | Not reported | +3.0% | Q2 2015 | |
| $318K | 1.39% | Not reported | -20.7% | Q1 2024 | |
| $268K | 1.17% | 0.02% | Not reported | Q2 2025 | |
| $187K | 0.82% | 0.03% | +23.1% | Q4 2022 | |
| BTBCAXBicara Therapeutics Inc. | $173K | 0.76% | 0.02% | Not reported | Q3 2024 |
| $138K | 0.60% | 0.05% | Not reported | Q1 2024 | |
| $115K | 0.50% | 0.03% | Not reported | Q4 2023 | |
| $26.6K | 0.12% | 0.02% | Not reported | Q4 2024 | |
| $22K | 0.10% | 0.02% | New | Q3 2025 | |
| $17.8K | 0.08% | 0.02% | Not reported | Q2 2024 | |
Premium opens every quarter this fund has filed